Mr. Brinder Singh Sandhu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 67 Elm Ave, Iselin, NJ 08830 Phone: 732-664-5964 |
Antara N Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 242 Winding Rd, Iselin, NJ 08830 Phone: 848-219-4928 |
Mr. Maulik V Shah Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 56 Reynolds St, Iselin, NJ 08830 Phone: 732-586-9990 Fax: 718-302-4851 |
Bela Patel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Avon Ter, Iselin, NJ 08830 Phone: 732-516-9774 Fax: 732-377-8678 |
Dr. Shikha Bhasin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Ronson Rd Apt 2203, Iselin, NJ 08830 Phone: 908-803-7765 |
Mohammed Khedr Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 908 Montague Ave, Iselin, NJ 08830 Phone: 908-342-4232 |
Smita Kembhavi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Cheryl Dr, Iselin, NJ 08830 Phone: 732-734-9589 |
News Archive
A specialized Lung Rescue Team established by clinicians at Massachusetts General Hospital to evaluate and treat patients with obesity receiving mechanical ventilation [MV] due to acute respiratory failure has significantly reduced the risk of mortality compared to standard treatment.
Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal.
Anavex Life Sciences Corp. today issued a statement following today's announcement from Pfizer and Medivation (MDVN) that their investigational Alzheimer's drug Dimebon did not meet either its co-primary or secondary endpoints compared to placebo during pivotal Phase 3 clinical trials.
Researchers have identified a mechanism that may keep a well known signaling molecule from eroding bone and inflaming joints, according to an early study published online today in the Journal of Clinical Investigation.
Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)
› Verified 9 days ago